Efficacy of vitamin K1 in the adjuvant treatment of pertussis syndrome
10.3760/cma.j.issn.1008-6706.2016.17.038
- VernacularTitle:维生素K1辅助治疗百日咳综合征的疗效分析
- Author:
Guohong WU
;
Zhenwen GAO
;
Jie MA
;
Dibin WANG
;
Xiuming HUANG
- Publication Type:Journal Article
- Keywords:
Vitamin K1;
Cough;
Pertussis syndrome
- From:
Chinese Journal of Primary Medicine and Pharmacy
2016;23(17):2706-2708
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the effects of vitamin K1 in the adjuvant treatment of spasmodic cough in pertussis syndrome children,and its impacts on length of hospital stay.Methods 87 pertussis syndrome children were randomly divided into two groups,among which 41 cases in the control group were treated with the therapies such as anti -infection,respiratory support,antispasmodic,expectorant et al,while 46 cases in the treatment group were treated additionally with vitamin K1 on the basis of the control group.Then compared the duration and hospital stay of the two groups with spasmodic cough.Results The disappeared time of spasmodic cough in the treatment group was (7.22 ±1.33)d and hospital stay was (9.52 ±1.84)d,which in the control group were (15.51 ±2.73)d,(18.71 ± 3.30)d respectively,and there were statistically significant differences(t =-18.310,-16.269,all P <0.01).In the treatment group,the total effective rate was 93.5%,there were 18 cases with markedly effective,25 cases with effective and 3 cases with ineffective.Correspondingly,there were 7 cases markedly effective,23 cases effective, 11 cases ineffective,and total efficiency rate was only 73.1% in the control group,the difference was statistically significant(χ2 =4.285,P <0.05 ).Conclusion Vitamin K1 to alleviate spasmodic cough in children has a significant effect,which can reduce the duration of the cough time and hospital stay in pertussis syndrome children, and also can improve the clinical effect.